Business Description
Cencora Inc
NAICS : 424210
SIC : 5122
ISIN : US03073E1055
Share Class Description:
STU:ABG: Ordinary SharesCompare
Compare
Traded in other countries / regions
COR.USAABC.AustriaABG.GermanyC1CO34.Brazil0HF3.UK IPO Date
2013-04-29Description
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.6 | |||||
| Equity-to-Asset | 0.01 | |||||
| Debt-to-Equity | 5.24 | |||||
| Debt-to-EBITDA | 1.29 | |||||
| Interest Coverage | 10.25 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.77 | |||||
| Beneish M-Score | -2.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.4 | |||||
| 3-Year EPS without NRI Growth Rate | 26.7 | |||||
| 3-Year FCF Growth Rate | 23.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 10.01 | |||||
| Future 3-5Y Total Revenue Growth Rate | 7 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.98 | |||||
| 9-Day RSI | 52.52 | |||||
| 14-Day RSI | 53.46 | |||||
| 6-1 Month Momentum % | 25.28 | |||||
| 12-1 Month Momentum % | 45.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.88 | |||||
| Quick Ratio | 0.52 | |||||
| Cash Ratio | 0.06 | |||||
| Days Inventory | 24.13 | |||||
| Days Sales Outstanding | 27.26 | |||||
| Days Payable | 61.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.83 | |||||
| Dividend Payout Ratio | 0.17 | |||||
| 3-Year Dividend Growth Rate | 5.3 | |||||
| Forward Dividend Yield % | 0.85 | |||||
| 5-Year Yield-on-Cost % | 1.06 | |||||
| 3-Year Average Share Buyback Ratio | 0.6 | |||||
| Shareholder Yield % | 4.74 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 3.42 | |||||
| Operating Margin % | 1.03 | |||||
| Net Margin % | 0.69 | |||||
| FCF Margin % | 1.34 | |||||
| ROE % | 419.89 | |||||
| ROA % | 3.06 | |||||
| ROIC % | 11.18 | |||||
| ROC (Joel Greenblatt) % | 122.74 | |||||
| ROCE % | 19.05 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.85 | |||||
| Forward PE Ratio | 17.79 | |||||
| PE Ratio without NRI | 20.62 | |||||
| Shiller PE Ratio | 70.29 | |||||
| Price-to-Owner-Earnings | 14.39 | |||||
| PS Ratio | 0.18 | |||||
| PB Ratio | 51.91 | |||||
| Price-to-Free-Cash-Flow | 13.29 | |||||
| Price-to-Operating-Cash-Flow | 11.81 | |||||
| EV-to-EBIT | 18.75 | |||||
| EV-to-Forward-EBIT | 16.1 | |||||
| EV-to-EBITDA | 13.27 | |||||
| EV-to-Forward-EBITDA | 12.81 | |||||
| EV-to-Revenue | 0.18 | |||||
| EV-to-Forward-Revenue | 0.17 | |||||
| EV-to-FCF | 13.55 | |||||
| Price-to-Projected-FCF | 1.82 | |||||
| Price-to-Median-PS-Value | 1.36 | |||||
| Earnings Yield (Greenblatt) % | 5.33 | |||||
| FCF Yield % | 7.68 | |||||
| Forward Rate of Return (Yacktman) % | 20.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cencora Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 251,897.222 | ||
| EPS (TTM) (€) | 8.503 | ||
| Beta | 0.35 | ||
| Volatility % | 15.9 | ||
| 14-Day RSI | 53.46 | ||
| 14-Day ATR (€) | 2.825 | ||
| 20-Day SMA (€) | 222.63 | ||
| 12-1 Month Momentum % | 45.08 | ||
| 52-Week Range (€) | 148.4 - 225.35 | ||
| Shares Outstanding (Mil) | 199.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cencora Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cencora Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cencora Inc Frequently Asked Questions
What is Cencora Inc(STU:ABG)'s stock price today?
The current price of STU:ABG is €222.40. The 52 week high of STU:ABG is €225.35 and 52 week low is €148.40.
When is next earnings date of Cencora Inc(STU:ABG)?
The next earnings date of Cencora Inc(STU:ABG) is 2024-05-01.
Does Cencora Inc(STU:ABG) pay dividends? If so, how much?
The Dividend Yield %  of Cencora Inc(STU:ABG) is 0.83% (As of Today), Highest Dividend Payout Ratio of Cencora Inc(STU:ABG) was 0.56. The lowest was 0.16. And the median was 0.2. The  Forward Dividend Yield % of Cencora Inc(STU:ABG) is 0.85%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers